These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 14698001

  • 21. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N, Margenthaler JA, Motoyama K, Arima T, Shimizu Y, Lehmann M, Flye MW.
    J Surg Res; 2001 Jun 01; 98(1):59-65. PubMed ID: 11368539
    [Abstract] [Full Text] [Related]

  • 22. The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells.
    Wasowska B, Baldwin WM, Howell DN, Sanfilippo F.
    Transplantation; 1991 Feb 01; 51(2):451-9. PubMed ID: 1994542
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism.
    Shirwan H, Wang HK, Barwari L, Makowka L, Cramer DV.
    Transplantation; 1996 May 15; 61(9):1382-6. PubMed ID: 8629301
    [Abstract] [Full Text] [Related]

  • 26. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P, Fuller J, Sanfilippo F.
    Transplantation; 1990 Jan 15; 49(1):175-83. PubMed ID: 2301009
    [Abstract] [Full Text] [Related]

  • 27. IgM and IgG alloantibody production by splenocytes and deposition in rat renal allografts are decreased by donor-specific blood transfusion.
    Baldwin WM, Rhoton K, Sanfilippo F.
    Transplantation; 1991 Feb 15; 51(2):481-5. PubMed ID: 1994544
    [Abstract] [Full Text] [Related]

  • 28. Intensity of transplant chronic rejection correlates with level of graft-infiltrating regulatory cells.
    Semiletova NV, Shen XD, Baibakov B, Andakyan A.
    J Heart Lung Transplant; 2010 Mar 15; 29(3):335-41. PubMed ID: 20080050
    [Abstract] [Full Text] [Related]

  • 29. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S, Salgar SK, Kurimoto Y, Yousem S, Pham SM.
    J Surg Res; 2008 May 15; 146(2):289-97. PubMed ID: 18314139
    [Abstract] [Full Text] [Related]

  • 30. Differential effects of pretreatment with ultraviolet-B modified or unmodified donor-specific leukocyte transfusions on intestinal and cardiac allograft survival in the rat.
    Gundlach M, Oluwole SF, D'Agati V, Supe D, Jin MX, Hardy MA.
    Transplantation; 1992 Mar 15; 53(3):613-9. PubMed ID: 1549854
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, Oluwole SF.
    Cell Transplant; 1999 Mar 15; 8(4):375-81. PubMed ID: 10478717
    [Abstract] [Full Text] [Related]

  • 33. Induction of donor-specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor MHC class I antigens.
    Oluwole SF, Chowdhury NC, Fawwaz RA.
    Transplantation; 1993 Jun 15; 55(6):1396-402. PubMed ID: 8516825
    [Abstract] [Full Text] [Related]

  • 34. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
    Chueh SC, Tian L, Wang M, Wang ME, Stepkowski SM, Kahan BD.
    Transplantation; 1997 Nov 27; 64(10):1407-14. PubMed ID: 9392303
    [Abstract] [Full Text] [Related]

  • 35. Tolerogenic protocol for intestinal transplantation.
    Pirenne J, Kawai M.
    Transplant Proc; 2006 Nov 27; 38(6):1664-7. PubMed ID: 16908241
    [Abstract] [Full Text] [Related]

  • 36. Histocompatibility differences and cardiac transplant tolerance produced by intrathymic pretreatment.
    Shen Z, Kline G, Mohiuddin M, DiSesa VJ.
    J Thorac Cardiovasc Surg; 1994 Jun 27; 107(6):1472-5. PubMed ID: 8196391
    [Abstract] [Full Text] [Related]

  • 37. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation: effect of donor-specific cell augmentation.
    Levay-Young B, Shearer JD, Gruessner AC, Kim SC, Nahkleh RE, Gruessner RW.
    Transplant Proc; 2004 Mar 27; 36(2):399-400. PubMed ID: 15050172
    [Abstract] [Full Text] [Related]

  • 38. The Leuven Immunomodulatory Protocol Promotes T-Regulatory Cells and Substantially Prolongs Survival After First Intestinal Transplantation.
    Ceulemans LJ, Braza F, Monbaliu D, Jochmans I, De Hertogh G, Du Plessis J, Emonds MP, Kitade H, Kawai M, Li Y, Zhao X, Koshiba T, Sprangers B, Brouard S, Waer M, Pirenne J.
    Am J Transplant; 2016 Oct 27; 16(10):2973-2985. PubMed ID: 27037650
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats.
    Nakano Y, Monden M, Valdivia LA, Gotoh M, Tono T, Mori T.
    Surgery; 1992 Jun 27; 111(6):668-76. PubMed ID: 1595063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.